AAAAAA

   
Results: 1-8 |
Results: 8
CLINICAL-SIGNIFICANCE OF YMDD MUTANT HEPATITIS-B VIRUS (HBV) IN A LARGE COHORT OF LAMIVUDINE-TREATED HEPATITIS-B PATIENTS
Authors: ATKINS M HUNT CM BROWN N GRAY F SANATHANAN L WOESSNER M LAI CL DUSHEIKO G DIENSTAG J WRIGHT T BARNARD J BOURNE E CONDREAY L
Citation: M. Atkins et al., CLINICAL-SIGNIFICANCE OF YMDD MUTANT HEPATITIS-B VIRUS (HBV) IN A LARGE COHORT OF LAMIVUDINE-TREATED HEPATITIS-B PATIENTS, Hepatology, 28(4), 1998, pp. 625-625
EFFICACY OF LAMIVUDINE RETREATMENT IN A PATIENT WITH HEPATITIS-B VIRUS (HBV) RECURRENCE AFTER LIVER-TRANSPLANTATION AND HBV-DNA BREAKTHROUGH DURING THE FIRST TREATMENT
Authors: MARZANO A DEBERNARDIVENON W CONDREAY L RIZZETTO M
Citation: A. Marzano et al., EFFICACY OF LAMIVUDINE RETREATMENT IN A PATIENT WITH HEPATITIS-B VIRUS (HBV) RECURRENCE AFTER LIVER-TRANSPLANTATION AND HBV-DNA BREAKTHROUGH DURING THE FIRST TREATMENT, Transplantation, 65(11), 1998, pp. 1499-1500
RESPONSE AND MUTATIONS IN PATIENTS SEQUENTIALLY TREATED WITH LAMIVUDINE AND FAMCICLOVIR FOR RECURRENT HEPATITIS-B AFTER LIVER-TRANSPLANTATION
Authors: TILLMANN HL TRAUTWEIN C BOCK T GLOWENKA M KRUGER M BOKER K JACKEL E PICHLMAYR R CONDREAY L BRUNS I DESLAURIAS M GAUTHIER J MANNS MP
Citation: Hl. Tillmann et al., RESPONSE AND MUTATIONS IN PATIENTS SEQUENTIALLY TREATED WITH LAMIVUDINE AND FAMCICLOVIR FOR RECURRENT HEPATITIS-B AFTER LIVER-TRANSPLANTATION, Hepatology, 26(4), 1997, pp. 1202-1202
LAMIVUDINE FOR CHRONIC HEPATITIS-B WITH TYPICAL AND ATYPICAL SEROLOGY
Authors: LAU DTY DOO E GHANY MG KLEINER DE PARK Y CONDREAY L HERION D LIANG TJ HOOFNAGLE JH
Citation: Dty. Lau et al., LAMIVUDINE FOR CHRONIC HEPATITIS-B WITH TYPICAL AND ATYPICAL SEROLOGY, Hepatology, 26(4), 1997, pp. 1203-1203
LAMIVUDINE-RESISTANT VIRUS IN THE DUCK MODEL REMAINS SUSCEPTIBLE TO 2-AMINO-6-METHOXY-2',3'-DIDEOXYPURINE
Authors: TYRRELL DLJ ROBBINS M CONDREAY L FISCHER KP
Citation: Dlj. Tyrrell et al., LAMIVUDINE-RESISTANT VIRUS IN THE DUCK MODEL REMAINS SUSCEPTIBLE TO 2-AMINO-6-METHOXY-2',3'-DIDEOXYPURINE, Hepatology, 26(4), 1997, pp. 1207-1207
HEPATITIS-B E-ANTIGEN (HBEAG) SEROCONVERSION IN 2 PATIENTS WITH EVIDENCE OF GENOTYPIC RESISTANCE FOLLOWING EXTENDED LAMIVUDINE TREATMENT
Authors: GARRETT L DIENSTAG JL GAUTHIER J CONDREAY L CROWTHER L GELB L SCHIFF ER BROWN NA
Citation: L. Garrett et al., HEPATITIS-B E-ANTIGEN (HBEAG) SEROCONVERSION IN 2 PATIENTS WITH EVIDENCE OF GENOTYPIC RESISTANCE FOLLOWING EXTENDED LAMIVUDINE TREATMENT, Hepatology, 26(4), 1997, pp. 1209-1209
LACK OF EFFECT OF ANTIVIRAL THERAPY IN NONDIVIDING HEPATOCYTE CULTURES ON THE CLOSED CIRCULAR DNA OF WOODCHUCK HEPATITIS-VIRUS
Authors: MORALEDA G SAPUTELLI J ADRICH CE AVERETT D CONDREAY L MASON WS
Citation: G. Moraleda et al., LACK OF EFFECT OF ANTIVIRAL THERAPY IN NONDIVIDING HEPATOCYTE CULTURES ON THE CLOSED CIRCULAR DNA OF WOODCHUCK HEPATITIS-VIRUS, Journal of virology, 71(12), 1997, pp. 9392-9399
EXTENDED LAMIVUDINE RETREATMENT FOR CHRONIC HEPATITIS-B
Authors: DIENSTAG JL SCHIFF ER MITCHELL M GITLIN N LISSOOS T CONDREAY L GARRETT L RUBIN M BROWN N
Citation: Jl. Dienstag et al., EXTENDED LAMIVUDINE RETREATMENT FOR CHRONIC HEPATITIS-B, Hepatology, 24(4), 1996, pp. 245-245
Risultati: 1-8 |